Ant Insurance Uses AI to Help Partner Insurers Process 7.25 Million Health Claims in 2024, Up 55% YoY
In 2024, leading insurers in China processed 7.25 million health claims through Ant Insurance, Ant Group's online insurance brokerage platform, marking a 55% year-over-year increase. Total health claim payouts on the platform reached RMB 9.2 billion (USD 1.3 billion). This growth is driven by ongoing innovations in product offerings and user experience, which build trust and meet user needs, while also reflecting the increasing demand for health insurance services.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250309812706/en/
Partner insurers processed 7.25 million health claims through Ant Insurance in 2024, up 55% year-over-year. (Photo: Business Wire)
The trend is expected to accelerate as China’s demographic patterns shift. By around 2035, over 400 million people, or more than 30% of the population, will be aged 60 or older, according to projections from China’s National Health Commission. As healthcare needs expand, commercial health insurance is becoming an essential complement to the country's basic medical system.
Ant Group has been leveraging innovative technologies to drive the digital transformation of the healthcare sector, with health insurance playing a key role.
Early in 2018, Ant Insurance introduced Haoyibao, a flagship health insurance product developed in partnership with leading insurers in China. It was the first in the country to offer guaranteed renewal for six consecutive years with payouts of up to RMB 4 million (USD 550,000). Over time, Haoyibao has been continually upgraded to support a wider range of people and health conditions. As a bestselling product, it has helped millions of families manage the financial burden of medical expenses.
With technologies like AI, Ant Insurance has streamlined every step of the insurance process - from product selection and planning to management and claims - making insurance services more accessible to the public.
The GoldenChoice feature uses the Ant Insurance Multi-factor Model (AIMM) to compare and select the best insurance products. Meanwhile, the EasyPick AI insurance planner creates personalized plans for users, helping them avoid overbuying or selecting the wrong coverage. In 2024, the AI-powered EasyClaims solution helped 11 partner insurers streamline the claims process for over 85 health insurance products, with AI handling 96% of the 1.62 million claims analysis requests from policyholders.
Further enhancing insurer capabilities, Ant Insurance launched Ant Bridge in September 2024. This open platform integrates AI models and financial intelligence to help insurers provide real-time, personalized responses to customer inquiries, improving service quality and operational efficiency.
Beyond insurance, Ant Group has been actively contributing to the digital transformation of China’s healthcare industry for over a decade. Since launching the country’s first online hospital appointment booking service in 2014, Ant Group’s Alipay digital platform has been assisting hospitals in developing digital services. As of January 2025, Alipay has connected more than 800 million users with services from over 3,600 hospitals.
In September 2024, Ant Group introduced the AI Healthcare Manager within the Alipay app. Available through voice and text interactions, this tool provides users with access to over 30 services, including doctor mapping, medical report interpretation, in-hospital navigation, and personalized medical advice.
Through these ongoing initiatives, Ant Group is contributing to the more efficient use of limited medical resources, with the aim of supporting greater medical inclusion.
About Ant Group
Ant Group aims to build the infrastructure and platforms to support the digital transformation of the service industry. Through continuous innovation, we strive to provide all consumers and small and micro businesses equal access to digital financial and other daily life services that are convenient, sustainable and inclusive.
For more information, please visit our website at www.antgroup.com or follow us on Twitter @AntGroup.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250309812706/en/
Contacts
Media Inquiries
Yinan Duan
duanyinan.dyn@antgroup.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CCM Biosciences Announces Presentation of Data on its First-In-Class AML Drug Program at ASCO 202520.5.2025 23:30:00 EEST | Press release
CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its next-generation FLT3 inhibitor drug program for acute myeloid leukemia (AML) at the 2025 Annual Conference of the American Society of Clinical Oncology (ASCO), taking place May 30 to June 3 in Chicago. Acute Myeloid Leukemia (AML) is the most severe form of leukemia with few treatment options, and a malignancy frequently driven by mutations in the FMS-like tyrosine kinase 3 (FLT3) gene. The FLT3 internal tandem duplication (ITD) and tyrosine kinase domain (TKD) mutations, particularly D835 and F691, appear in approximately 30% of AML patients, often leading to poor prognosis and resistance to existing therapies. Gilteritinib (Xospata®; Astellas Pharma, peak annual sales projection: $1.5 billion) and Quizartinib (Vanflyta®; Daiichi Sankyo) are two FDA-approved FLT3 inhibitors, with the former approved only for relapsed/refractory AML and the latter approved o
IonQ Partners with Sweden’s Einride to Develop Quantum Supply Chain and Quantum-Enhanced Logistics for Autonomous Driving Solutions20.5.2025 23:05:00 EEST | Press release
IonQ (NYSE: IONQ), a leading commercial quantum computing and networking company, today announced an investment partnership with Einride, a leading global freight mobility company that provides digital, electric, and autonomous technology to explore how quantum computing can drive the next generation of fleet optimization and logistics. Together, IonQ and Einride will develop quantum applications that address large-scale routing and scheduling problems that have traditionally challenged classical computing. By combining IonQ’s advanced quantum systems with Einride’s expertise in autonomous fleet logistics, the two companies will work to unlock new levels of efficiency, reliability, and sustainability for the global freight industry. “Einride shares our belief that quantum computing will fundamentally reshape and improve how large industries such as transportation and logistics operate,” said Niccolo de Masi, CEO of IonQ. “This partnership is aimed at creating a powerful platform with u
CCM Biosciences Announces Presentation of Data on its First-In-Class NSCLC Drug Program at ASCO 202520.5.2025 22:26:00 EEST | Press release
CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its 4th-generation EGFR inhibitor drug program for non-small cell lung cancer (NSCLC) at the 2025 Annual Conference of the American Society of Clinical Oncology (ASCO), taking place May 30 to June 3 in Chicago. NSCLC, which accounts for 80% of lung cancer, is the most common cause of cancer death worldwide. Epidermal growth factor receptor (EGFR)-activating mutations (Del19 or L858R) are major oncogenic drivers of NSCLC. EGFR-positive NSCLC accounts for approximately 30% of all diagnosed cases of NSCLC (a similar market size to PD-L1-positive NSCLC, which is addressed by the world’s top-selling drug, Keytruda®). The current standard of care for EGFR-positive NSCLC is comprised of 3rd-generation inhibitors, most notably Osimertinib (Tagrisso®), whose annual sales exceed $6 billion. Most patients treated by tyrosine kinase inhibitors (TKIs) will eventually develop
NielsenIQ's Chief Technology Officer Mohit Kapoor Named Executive of the Year at Global Tech & AI Awards for Leading NIQ’s AI-Driven Tech Transformation20.5.2025 22:24:00 EEST | Press release
NielsenIQ (NIQ) is proud to announce that Mohit Kapoor, Chief Technology Officer, was named Executive of the Year at the inaugural Global Tech & AI Awards. This honor recognizes Mohit's exceptional leadership and visionary contributions to the tech industry, particularly in the realm of AI-powered consumer intelligence. "I am deeply honored to receive the Executive of the Year award at the Global Tech & AI Awards. This recognition is a testament to the incredible work and dedication of the entire NielsenIQ team,” said Mohit Kapoor, Chief Technology Officer, NIQ. “Together, we have redefined consumer and retail intelligence, leveraging AI to deliver unparalleled insights and drive meaningful change in the industry." Under Mohit's leadership, NIQ has adopted an AI-powered approach to its ambitious digital transformation which included a $400 million technology investment and the migration of its global client base onto Discover– a unified, cloud-based platform that seamlessly integrates
Strategic Partnership Between the Government of Morocco and TAQA Morocco, Nareva, ONEE and the Mohammed VI Investment Fund to Develop Key Power and Water Infrastructures in the Kingdom of Morocco20.5.2025 22:08:00 EEST | Press release
As part of the implementation of the commitments made in the joint declaration between His Majesty King Mohammed VI, may God Assist Him, and His Highness Sheikh Mohamed bin Zayed Al Nahyan, TAQA Morocco, in partnership with Nareva and the Mohammed VI Fund for Investment, has signed three memorandums of understanding and related development agreements with the Government of Morocco and ONEE. These agreements cover the development of structuring projects in the power, water and renewable energy sectors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250520313620/en/ Strategic Partnership Between the Government of Morocco and TAQA Morocco, Nareva, ONEE and the Mohammed VI Investment Fund to Develop Key Power and Water Infrastructures in the Kingdom of Morocco (Photo: AETOSWire) The program aims to strengthen the Kingdom's water and energy sovereignty through the development of flexible natural gas-based power generation capacit
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom